Corporate profile
Mesoblast is commercializing innovative biological therapies for the emerging field of regenerative medicine. The company is developing adult stem cell-based therapeutics for the treatment of cardiovascular and neurological conditions, diabetes, eye diseases, bone marrow regeneration after cancer, bone fractures, cartilage degeneration of the knee and vertebrae and musculoskeletal conditions. The Mesenchymal Precursor Cell technology platform is patented and has been exclusively acquired for worldwide commercial application.